title: Rationale for the treatment of cancer with sodium selenite.
abstract: Epidemiological studies conducted during several decades of the last century have demonstrated the importance of sufficient nutritional supply of selenium (Se) for human health. More importantly, low blood Se levels were found to be associated with an increased incidence and mortality from various types of cancers. Recently, attention of researchers was drawn to the relationship between free radical generation, known otherwise as oxidative stress, and carcinogenesis. It was therefore thought that antioxidants should be beneficial for prevention and inhibition of different malignancies. However, there appeared to be a paradox, because tumor growth is associated with tissue hypoxia that is accompanied by the formation of reductive rather than oxidative free radicals. Various organic and inorganic Se compounds, generally considered to be antioxidants, produced mixed results when tested in animal models and human subjects. Amongst them, sodium selenite has been shown to be the most effective in an in vitro and in vivo carcinogenesis studies. As recently demonstrated, selenite is not an antioxidant, but possesses oxidizing properties in the presence of specific substrates. Thus selenite is capable of oxidizing polythiols to corresponding disulfides, but does not react with monothiols. Such polythiols associated with cancer membrane-bound proteins appear under the reducing conditions of hypoxic tumor tissue. These thiol groups can, in turn, initiate a disulfide exchange reaction with plasma proteins, predominantly with fibrinogen, to form an insoluble and protease-resistant fibrin-like polymer. As the result, tumor cells become surrounded by a coat which masks specific tumor antigens thus allowing cancer cells to escape immune recognition and elimination by natural killer (NK) cells. Selenite by virtue of oxidizing cell membrane thiols, can prevent the formation of the coat and consequently makes cancer cells vulnerable to the immune surveillance and destruction. In addition, selenite may directly activate NK cells, as well as inhibit angiogenesis without undesirable decrease in the oxidative potential of cellular environment. It is, therefore, postulated that sodium selenite, in view of its relative low toxicity, might become a drug of choice for many types of cancer including leukemia.
authors.affiliation: H.S. Research, P.O. Box 1815, Boston, MA 02460, USA. blipinski@sprintmail.com
authors.forename: Boguslaw
authors.initials: B
authors.lastname: Lipinski
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010084:Oxidation-Reduction; D018038:Sodium Selenite / Q000627:therapeutic use*
chemical_list: D018038:Sodium Selenite